Serotonin transporter gene and adverse life events in adult ADHD

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 8, 2008, Pages 1461-1469

  Müller, Daniel J ^a,b   Mandelli, Laura ^c   Serretti, Alessandro ^c   DeYoung, Colin G ^d   De Luca, Vincenzo ^b   Sicard, Tricia ^b   Tharmalingam, Subi ^b   Gallinat, Jürgen ^a   Muglia, Pierandrea ^b   De Ronchi, Diana ^c   Jain, Umesh ^b   Kennedy, James L ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d YALE UNIVERSITY   (United States)

Author keywords

Adult ADHD; Gene environment interaction; Life events; Serotonin transporter gene

Indexed keywords

CATECHOL METHYLTRANSFERASE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REGRESSION ANALYSIS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 55349147126     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30706     Document Type: Article

References (78)

1. Allen NB, Lewinsohn PM, Seeley JR. 1998. Prenatal and perinatal influences on risk for psychopathology in childhood and adolescence. Dev Psychopathol 10:513-529.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders 4th edition. Washington DC: American Psychiatric Association.
3. Arnsten AF. 1997. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11:151-162.
4. Asherson P. 2005. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 5:525-539.
5. Barr CL, Kroft J, Feng Y, Wigg K, Roberts W, Malone M, Ickowicz A, Schachar R, Tannock R, Kennedy JL. 2002. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet 114:255-259.
6. Beitchman JH, Davidge KM, Kennedy JL, Atkinson L, Lee V, Shapiro S, Douglas L. 2003. The serotonin transporter gene in aggressive children with and without ADHD and nonaggressive matched controls. Ann NY Acad Sci 1008:248-251.
7. Bennett AJ, Lesch KP, Heils A, Long JC, Lorenz JG, Shoaf SE, Champoux M, Suomi SJ, Linnoila MV, Higley JD. 2002. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 7:118-122.
8. Biederman J. 2005. Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 57:1215-1220.
9. Biederman J, Newcorn J, Sprich S. 1991. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577.
10. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E. 1995. Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry 52:464-470.
11. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T. 1996. Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 35:343-351.
12. Biederman J, Faraone SV, Monuteaux MC. 2002. Differential effect of environmental adversity by gender: Rutter's index of adversity in a group of boys and girls with and without ADHD. Am J Psychiatry 159:1556-1562.
13. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV. 2006. Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychol Med 36:167-179.
14. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, Goldman RS, Hoptman MJ, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Kunz M, Chakos M, Cooper TB, Lieberman JA. 2002. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52:701-707.
15. Blanz B, Schmidt MH, Esser G. 1991. Familial adversities and child psychiatric disorders. J Child Psychol Psychiatry 32:939-950.
16. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen LS, Sharp WS, Inoff-Germain G, Wavrant-De Vrieze F, Arcos-Burgos M, Straub RE, Hardy JA, Castellanos FX, Rapoport JL. 2005. Support for association between ADHD and two candidate genes: NET1 and D RD1. Am J Med Genet Part B 134B:67-72.
17. Bremne JD, Vermetten E. 2001. Stress and development: Behavioral and biological consequences. Dev Psychopathol 13:473-489.
18. Brown T. 1996. Brown Attention-Deficit Disorder Scales. Toronto, Ontario: The Psychological Corporation.
19. Brown GW, Harris TO. 1978. The Bedford College Life-Events and Difficulty Schedule: Directory of contextual threat ratings of events. Unpublished manuscript. University of London: Bedford College.
20. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
21. Cheuk DK, Wong V. 2006. Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 36(5):651-659.
22. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates. pp 8-14.
23. Conners CK. 1999. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Am 46:857-870, vi.
24. Conners CK, Erhardt D, Sparrow E. 1999. Conners' Adult ADHD Rating Scales, Technical Manual. New York, NY: Multi-Health Systems.
25. Counts CA, Nigg JT, Stawicki JA, Rappley MD, von Eye A. 2005. Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems. J Am Acad Child Adolesc Psychiatry 44:690-698.
26. Cuffe SP, McKeown RE, Jackson KL, Addy CL, Abramson R, Garrison CZ. 2001. Prevalence of attention-deficit/hyperactivity disorder in a community sample of older adolescents. J Am Acad Child Adolesc Psychiatry 40:1037-1044.
27. Curran S, Purcell S, Craig I, Asherson P, Sham P. 2005. The serotonin transporter gene as a QTL for ADHD. Am J Med Genet Part B 134B:42-47.
28. De Luca V, Muglia P, Jain U, Kennedy JL. 2004a. No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD. Am J Med Genet Part B 124B:38-40.
29. De Luca V, Muglia P, Vincent JB, Lanktree M, Jain U, Kennedy JL. 2004b. Adrenergic alpha 2C receptor genomic organization: Association study in adult ADHD. Am J Med Genet Part B 127B:65-67.
30. Faraone SV, Biederman J. 1999. The neurobiology of attention deficit hyperactivity disorder. In: Charney DS, Nestler EJ, Bunney BS, editors. "Neurobiology of Mental Ilness". New York, NY: Oxford University Press. pp 788-801.
31. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. 2000. Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry 48:9-20.
32. Faraone SV, Biederman J, Mick E. 2006. The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychol Med 36:159-165.
33. First MB, Spitzer RL, Gibbon M, Williams JB. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department: New York State Psychiatric Institute.
34. Ford JD, Racusin R, Daviss WB, Ellis CG, Thomas J, Rogers K, Reiser J, Schiffman J, Sengupta A. 1999. Trauma exposure among children with oppositional defiant disorder and attention deficit-hyperactivity disorder. J Consult Clin Psychol 67:786-789.
35. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
36. Hariri AR, Holmes A. 2006. Genetics of emotional regulation: The role of the serotonin transporter in neural function. Trends Cogn Sci 10:182-191.
37. Hariri AR, Mattay VS, Tessitore A, Fera F, Weinberger DR. 2003. Neocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry 53:494-501.
38. Harpin VA. 2005. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child 90(Suppl 1):i2-i7.
39. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D. 2006. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826.
40. Ishii G, Suzuki A, Oshino S, Shiraishi H, Otani K. 2007. CYP2C19 polymorphism affects personality traits of Japanese females. Neurosci Lett 411:77-80. Epub 2006 Oct 18.
41. Johann M, Bobbe G, Putzhammer A, Wodarz N. 2003. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: Differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor). Alcohol Clin Exp Res 27:1527-1534.
42. Kai-Uwe Kühn KM, Nöthen MM, Michael G, Andreas P, Wolfgang M. 1999. Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: Replication tests. Am J Med Genet 88:168-172.
43. Kalbag AS, Levin FR. 2005. Adult ADHD and substance abuse: Diagnostic and treatment issues. Subst Use Misuse 40:1955-1981, 2043-2048.
44. Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z, Kirley A, Lowe N, Fitzgerald M, Gill M, Craddock N. 2002. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): Analysis and pooled analysis. Mol Psychiatry 7:908-912.
45. Kraemer GW, Ebert MH, Schmidt DE, McKinney WT. 1989. A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys. Neuropsychopharmacology 2:175-189.
46. Lahiri DK, Nurnberger JI Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
47. Langley K, Payton A, Hamshere ML, Pay HM, Lawson DC, Turic D, Ollier W, Worthington J, Owen MJ, O'Donovan MC, Thapar A. 2003. No evidence of association of two 5HT transporter gene polymorphisms and attention deficit hyperactivity disorder. Psychiatr Genet 13:107-1010.
48. Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, Del Favero J, Dikeos DG, Kaneva R, Lilli R, Massat I, Milanova V, Muir W, Noethen M, Oruc L, Petrova T, Papadimitriou GN, Rietschel M, Serretti A, Souery D, Van Gestel S, Van Broeckhoven C, Mendlewicz J. 2001. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry 6:579-585.
49. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety-related traitswith a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
50. Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH, McEwen BS. 2006. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 26:7870-7874.
51. Lynn DE, Lubke G, Yang M, McCracken JT, McGough JJ, Ishii J, Loo SK, Nelson SF, Smalley SL. 2005. Temperament and character profiles and the dopamine D4 receptor gene in ADHD. Am J Psychiatry 162:906-913.
52. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP, Kotler M. 2001. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 105:91-95.
53. McEvoy B, Hawi Z, Fitzgerald M, Gill M. 2002. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am J Med Genet 114:665-666.
54. McGough JJ, Barkley RA. 2004. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 161:1948-1956.
55. Muglia P, Jain U, Macciardi F, Kennedy JL. 2000. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 96:273-277.
56. Muglia P, Jain U, Inkster B, Kennedy JL. 2002. A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD. Neuropsychopharmacology 27:655-662.
57. Nakamura M, Ueno S, Sano A, Tanabe H. 2000. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5:32-38.
58. Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, Herscovitch P, Goldman D, Drevets WC, Charney DS. 2006. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63:978-986.
59. Paykel ES, Prusoff BA, Uhlenhuth EH. 1971. Scaling of life events. Arch Gen Psychiatry 25:340-347.
60. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV. 2003. Family-based and case-control association studies of catechol-O- methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet Part B 118B:103-109.
61. Rey JM, Walter G, Plapp JM, Denshire E. 2000. Family environment in attention deficit hyperactivity, oppositional defiant and conduct disorders. Aust N Z J Psychiatry 34:453-457.
62. Scahill L, Schwab-Stone M, Merikangas KR, Leckman JF, Zhang H, Kasl S. 1999. Psychosocial and clinical correlates of ADHD in a community sample of school-age children. J Am Acad Child Adolesc Psychiatry 38:976-984.
63. Seeger G, Schloss P, Schmidt MH. 2001. Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 6:235-238.
64. Seidman LJ, Valera EM, Makris N. 2005. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1263-1272.
65. Serretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Di Bella D, Catalano M, Smeraldi E. 1999. No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. Am J Med Genet 88:44-49.
66. Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N. 1990. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 31:416-425.
67. Solanto MV. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res 94:127-152.
68. Stahl SM. 2003. Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: Both dopamine and norepinephrine increase in prefrontal cortex. J Clin Psychiatry 64:230-231.
69. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P. 1996. Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67:523-532.
70. Thapar A, van den Bree M, Fowler T, Langley K, Whittinger N. 2006. Predictors of antisocial behaviour in children with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 15:118-125.
71. Waldman ID, Gizer IR. 2006. The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev 26:396-432.
72. Ward MF, Wender PH, Reimherr FW. 1993. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885-890.
73. Weinberg WA, Emslie GJ. 1991. Attention deficit hyperactivity disorder: The differential diagnosis. J Child Neurol 6(Suppl):S23-S36.
74. Wigg KG, Takhar A, Ickowicz A, Tannock R, Kennedy JL, Pathare T, Malone M, Schachar R, Barr CL. 2006. Gene for the serotonin transporter and ADHD: No association with two functional polymorphisms. Am J Med Genet B Neuropsychiatr Genet. 141(6):566-570.
75. Xu X, Mill J, Chen CK, Brookes K, Taylor E, Asherson P. 2005. Family-based association study of serotonin transporter gene polymorphisms in attention deficit hyperactivity disorder: No evidence for association in UK and Taiwanese samples. Am J Med Genet Part B 139B:11-13.
76. Zametkin AJ, Liotta W. 1998. The neurobiology of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 59 (Suppl 7):17-23.
77. Zametkin AJ, Rapoport JL. 1987. Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26:676-686.
78. Zoroglu SS, Erdal ME, Alasehirli B, Erdal N, Sivasli E, Tutkun H, Savas HA, Herken H. 2002. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 45:176-181.